Skip to main content
. 2020 Mar 25;21:137–149. doi: 10.1016/j.jor.2020.03.016

Table 8.

Total WOMAC values before and after viscosupplementation.

Study/Interval Baseline
Follow-Up
p-value
Mean SD Mean SD
1-month
Clementi et al. 201819
UHMW 69.3 19.6 60.1 18.3
MMW 69.8 21 59.5 18.8
Spitzer et al. 201051 64.27 1.27 <0.0001
Dıraçoğlu et al. 200939 17.26 2.49 12.27 2.40 <0.001
Tikiz et al. 200531 63.9 21.3 37.1 28.4 <0.001
3-months
Clementi et al. 201819
UHMW 69.3 19.6 56.8 14.5
MMW 69.8 21 57.1 17.4
Suppan et al. 201754 57.4 1.37* 79 1.13* <0.001
Tikiz et al. 200531 63.9 21.3 43.6 31.4 <0.001
Conrozier et al. 200346 157.2 53.5 104 79.7 <0.0001
6-months
Clementi et al. 201819
UHMW 69.3 19.6 56.5 14.5
MMW 69.8 21 57.1 17.4
Tikiz et al. 200531 63.9 21.3 38.7 30.3 <0.001
Pourbagher et al.45 41.6 1.96 20 6.02 <0.05
26-weeks
Spitzer et al. 201051 64.27 1.27 <0.0001
12-months
Clementi et al. 201819
UHMW 69.3 19.6 57.2 13.7
MMW 69.8 21 57.1 16

*Values reported as Standard Error of the Mean (SEM).

UHMW: Ultra High Molecular Weight; MMW: Medium Molecular Weight; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; SD: standard deviation.